Ionis Pharmaceuticals (IONS) Depreciation & Amortization (CF) (2013 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Depreciation & Amortization (CF) of $3.4 million for Q2 2026, up 51.5% year-over-year from $2.3 million in Q2 2025, and up 4.0% quarter-over-quarter from $3.3 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $3.4 million for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 51.5% year-over-year to $3.4 million; the TTM figure through Jun 2026 stood at $12.2 million (up 34.67% YoY), while the FY2025 annual figure was $10.0 million, up 4.1% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $3.4 million, up from $3.3 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $3.8 million in Q3 2022, with the low at $2.2 million in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $2.6 million (2023), against an average of $2.8 million.
- The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) tumbled 33.9% in 2023, then soared 51.5% in 2026.
- Ionis Pharmaceuticals' Depreciation & Amortization (CF) stood at $3.0 million in 2022, then dropped by 15.96% to $2.5 million in 2023, then fell by 11.95% to $2.2 million in 2024, then surged by 45.49% to $3.3 million in 2025, then climbed by 5.34% to $3.4 million in 2026.
- Business Quant data shows IONS's Depreciation & Amortization (CF) at $3.4 million in Q2 2026, $3.3 million in Q1 2026, and $3.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 3.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.43 Mn |
| Jun 30, 2026 | 3.43 Mn |
| Mar 31, 2026 | 3.30 Mn |
| Mar 31, 2026 | 3.30 Mn |
| Dec 31, 2025 | 3.26 Mn |
| Dec 31, 2025 | 3.26 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 2.24 Mn |
| Dec 31, 2024 | 2.24 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.55 Mn |